{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:02:45Z","timestamp":1773270165900,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32-\u00ad CA-\u00ad 236621"],"award-info":[{"award-number":["T32-\u00ad CA-\u00ad 236621"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We aimed to understand patients\u2019 initial experiences with targeted oral anticancer agents (OAAs). We investigated symptoms experienced and how symptom severity affected patient confidence to manage and seek care for symptoms and OAA adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a longitudinal prospective cohort study of patients during the first 8 weeks of targeted OAA treatment at an NCI-designated cancer center. Participants completed patient-reported outcome measures (PROMs) online at three timepoints. Descriptive statistics quantified demographics, cancer characteristics, symptom severity, confidence, and OAA adherence. Logistic regression was used to estimate confidence and adherence by each symptom at each timepoint. Mixed effects logistic regressions accounted for repeated measures and time effects on outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200959) reported severe symptoms at all timepoints. Tiredness and drowsiness were most frequently reported as severe. Participants\u2019 confidence increased from timepoint 1 to 3. Most participants reported high confidence (61\u201386%) and excellent adherence (75\u201380%) across all timepoints, but 20\u201325% had less than excellent OAA adherence. High confidence to manage symptoms was positively associated with older age. Confidence to manage symptoms was inversely related to the severity of depression, tiredness, drowsiness, constipation, and tingling\/numbness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Confidence to manage symptoms increased with time on OAAs, but severe symptoms persisted. Although self-reported OAA adherence was high, a notable number of participants reported suboptimal adherence. Relationships between confidence, symptom severity, and adherence should be identified in clinical settings to evaluate patients who may need extra clinical support during OAA treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10421-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:46:33Z","timestamp":1770965193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient symptoms, confidence, and adherence during the first 8 weeks of targeted oral anticancer agent treatment"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5407-9070","authenticated-orcid":false,"given":"Amna","family":"Rizvi-Toner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5723-0443","authenticated-orcid":false,"given":"Antoinette B.","family":"Coe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-2056","authenticated-orcid":false,"given":"Christopher R.","family":"Friese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6101-5535","authenticated-orcid":false,"given":"Milisa","family":"Manojlovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8617","authenticated-orcid":false,"given":"Lauren P.","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5636-3009","authenticated-orcid":false,"given":"Karen B.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"2","key":"10421_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00520-024-09136-4","volume":"33","author":"F Angus","year":"2025","unstructured":"Angus F, Liao WC, Adekoya V, Chen LC (2025) The effect of healthcare professional-implemented interventions on adherence to oral targeted therapy in patients with cancer: a systematic review and meta-analysis. Support Care Cancer 33(2):110. https:\/\/doi.org\/10.1007\/s00520-024-09136-4","journal-title":"Support Care Cancer"},{"issue":"53","key":"10421_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgz008","volume":"2019","author":"DMK Keefe","year":"2019","unstructured":"Keefe DMK, Bateman EH (2019) Potential successes and challenges of targeted cancer therapies. J Natl Cancer Inst Monogr 2019(53):lgz008. https:\/\/doi.org\/10.1093\/jncimonographs\/lgz008","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"10421_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1188\/15.ONF.42-01P","volume":"42","author":"SL Spoelstra","year":"2015","unstructured":"Spoelstra SL, Given CW, Sikorskii A, Majumder A, Schueller M, Given BA (2015) Treatment with oral anticancer agents: symptom severity and attribution, and interference with comorbidity management. Oncol Nurs Forum 42(1):80\u201388. https:\/\/doi.org\/10.1188\/15.ONF.42-01P","journal-title":"Oncol Nurs Forum"},{"issue":"6","key":"10421_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ctrv.2012.12.014","volume":"39","author":"M Verbrugghe","year":"2013","unstructured":"Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A (2013) Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev 39(6):610\u2013621. https:\/\/doi.org\/10.1016\/j.ctrv.2012.12.014","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10421_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/14737140.2016.1159515","volume":"16","author":"WC Huang","year":"2016","unstructured":"Huang WC, Chen CY, Lin SJ, Chang CS (2016) Medication adherence to oral anticancer drugs: systematic review. Expert Rev Anticancer Ther 16(4):423\u2013432. https:\/\/doi.org\/10.1586\/14737140.2016.1159515","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10421_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3322\/caac.20093","volume":"61","author":"R McCorkle","year":"2011","unstructured":"McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, Wagner EH (2011) Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 61(1):50\u201362. https:\/\/doi.org\/10.3322\/caac.20093","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10421_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2450","volume":"3","author":"DR Rivera","year":"2017","unstructured":"Rivera DR, Gallicchio L, Brown J, Liu B, Kyriacou DN, Shelburne N (2017) Trends in adult cancer-related emergency department utilization: an analysis of data from the nationwide emergency department sample. JAMA Oncol 3(10):e172450. https:\/\/doi.org\/10.1001\/jamaoncol.2017.2450","journal-title":"JAMA Oncol"},{"issue":"1","key":"10421_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50423","volume":"6","author":"A Alishahi Tabriz","year":"2023","unstructured":"Alishahi Tabriz A, Turner K, Hong YR, Gheytasvand S, Powers BD, Elston Lafata J (2023) Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US. JAMA Netw Open 6(1):e2250423. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50423","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10421_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027942","volume":"9","author":"M Bana","year":"2019","unstructured":"Bana M, Ribi K, Kropf-Staub S, Z\u00fcrcher-Florin S, N\u00e4f E, Manser T, B\u00fctikofer L, Rintelen F, Peters S, Eicher M (2019) Implementation of the Symptom Navi \u00a9 programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi\u00a9 pilot study). BMJ Open 9(7):e027942. https:\/\/doi.org\/10.1136\/bmjopen-2018-027942","journal-title":"BMJ Open"},{"issue":"1","key":"10421_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ecc.12303","volume":"25","author":"A Coolbrandt","year":"2016","unstructured":"Coolbrandt A, de Dierckx Casterl\u00e9 B, Wildiers H, Aertgeerts B, der Van Elst E, van Achterberg T, Milisen K (2016) Dealing with chemotherapy-related symptoms at home: a qualitative study in adult patients with cancer. Eur J Cancer Care (Engl) 25(1):79\u201392. https:\/\/doi.org\/10.1111\/ecc.12303","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"10421_CR11","doi-asserted-by":"publisher","first-page":"E272","DOI":"10.1188\/17.CJON.E272-E279","volume":"21","author":"LL White","year":"2017","unstructured":"White LL, Cohen MZ, Berger AM, Kupzyk KA, Swore-Fletcher BA, Bierman PJ (2017) Perceived self-efficacy: a concept analysis for symptom management in patients with cancer. Clin J Oncol Nurs 21(6):E272\u2013E279. https:\/\/doi.org\/10.1188\/17.CJON.E272-E279","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10421_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1188\/19.ONF.113-128","volume":"46","author":"LL White","year":"2019","unstructured":"White LL, Cohen MZ, Berger AM, Kupzyk KA, Bierman PJ (2019) Self-efficacy for management of symptoms and symptom distress in adults with cancer: an integrative review. Oncol Nurs Forum 46(1):113\u2013128. https:\/\/doi.org\/10.1188\/19.ONF.113-128","journal-title":"Oncol Nurs Forum"},{"issue":"6","key":"10421_CR13","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00520-017-3584-0","volume":"25","author":"TM Salgado","year":"2017","unstructured":"Salgado TM, pana E, Severson JA, Lindsay J, Batra P, Petersen L, Farris KB (2017) The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices. Support Care Cancer 25(6):1797\u20131807. https:\/\/doi.org\/10.1007\/s00520-017-3584-0","journal-title":"Support Care Cancer"},{"issue":"3","key":"10421_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/1077558715573871","volume":"72","author":"JH Hibbard","year":"2015","unstructured":"Hibbard JH, Greene J, Shi Y, Mittler J, Scanlon D (2015) Taking the long view: how well do patient activation scores predict outcomes four years later? Med Care Res Rev 72(3):324\u2013337. https:\/\/doi.org\/10.1177\/1077558715573871","journal-title":"Med Care Res Rev"},{"issue":"5","key":"10421_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.pec.2015.02.005","volume":"98","author":"RL Kinney","year":"2015","unstructured":"Kinney RL, Lemon SC, Person SD, Pagoto SL, Saczynski JS (2015) The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: a systematic review. Patient Educ Couns 98(5):545\u2013552. https:\/\/doi.org\/10.1016\/j.pec.2015.02.005","journal-title":"Patient Educ Couns"},{"issue":"1","key":"10421_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00520-021-06466-5","volume":"30","author":"J Papadakos","year":"2022","unstructured":"Papadakos J, Barnsley J, Berta W, Rowlands G, Samoil D, Howell D (2022) The association of self-efficacy and health literacy to chemotherapy self-management behaviors and health service utilization. Support Care Cancer 30(1):603\u2013613. https:\/\/doi.org\/10.1007\/s00520-021-06466-5","journal-title":"Support Care Cancer"},{"issue":"8","key":"10421_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18084266","volume":"18","author":"A Talens","year":"2021","unstructured":"Talens A, Guilabert M, Lumbreras B, Aznar MT, L\u00f3pez-Pintor E (2021) Medication experience and adherence to oral chemotherapy: a qualitative study of patients\u2019 and health professionals\u2019 perspectives. Int J Environ Res Public Health 18(8):4266. https:\/\/doi.org\/10.3390\/ijerph18084266","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10421_CR18","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00520-021-06663-2","volume":"30","author":"P Nizet","year":"2022","unstructured":"Nizet P, Touchefeu Y, Pecout S, Cauchin E, Beaudouin E, Mayol S, Fronteau C, Huon JF (2022) Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study. Support Care Cancer 30(3):2591\u20132604. https:\/\/doi.org\/10.1007\/s00520-021-06663-2","journal-title":"Support Care Cancer"},{"issue":"21","key":"10421_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182111045","volume":"18","author":"TC Davis","year":"2021","unstructured":"Davis TC, Arnold CL, Mills G, Lesser GJ, Brown WM, Schulz R, Weaver KE, Pawloski PA (2021) Assessment of oral chemotherapy nonadherence in chronic myeloid leukemia patients using brief measures in community cancer clinics: a pilot study. Int J Environ Res Public Health 18(21):11045. https:\/\/doi.org\/10.3390\/ijerph182111045","journal-title":"Int J Environ Res Public Health"},{"issue":"19","key":"10421_CR20","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1002\/cam4.4201","volume":"10","author":"LP Spees","year":"2021","unstructured":"Spees LP, Wheeler SB, Jackson BE, Baggett CD, Wilson LE, Greiner MA, Kaye DR, Zhang T, George D, Scales CD Jr, Pritchard JE, Leapman M, Gross CP, Dinan MA (2021) Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Cancer Med 10(19):6653\u20136665. https:\/\/doi.org\/10.1002\/cam4.4201","journal-title":"Cancer Med"},{"issue":"12","key":"10421_CR21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00520-023-08122-6","volume":"31","author":"TH Dang","year":"2023","unstructured":"Dang TH, O\u2019Callaghan C, Alexander M, Burbury K, Jayaraman PP, Wickramasinghe N, Schofield P (2023) Take the tablet or don\u2019t take the tablet?\u201d-A qualitative study of patients\u2019 experiences of self-administering anti-cancer medications related to adherence and managing side effects. Support Care Cancer Off J Multinational Association Support Care Cancer 31(12):680. https:\/\/doi.org\/10.1007\/s00520-023-08122-6","journal-title":"Support Care Cancer Off J Multinational Association Support Care Cancer"},{"issue":"5","key":"10421_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jgo.2022.01.008","volume":"13","author":"DR Kaye","year":"2022","unstructured":"Kaye DR, Wilson LE, Greiner MA, Spees LP, Pritchard JE, Zhang T, Pollack CE, George D, Scales CD Jr, Baggett CD, Gross CP, Leapman MS, Wheeler SB, Dinan MA (2022) Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma. J Geriatr Oncol 13(5):614\u2013623. https:\/\/doi.org\/10.1016\/j.jgo.2022.01.008","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"10421_CR23","doi-asserted-by":"publisher","first-page":"831","DOI":"10.18553\/jmcp.2022.28.8.831","volume":"28","author":"A Vyas","year":"2022","unstructured":"Vyas A, Descoteaux A, Kogut S, Parikh MA, Campbell PJ, Green A, Westrich K (2022) Predictors of adherence to oral anticancer medications: an analysis of 2010-2018 US nationwide claims. J Manag Care Spec Pharm 28(8):831\u2013844. https:\/\/doi.org\/10.18553\/jmcp.2022.28.8.831","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10421_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081375","volume":"14","author":"A Rizvi-Toner","year":"2024","unstructured":"Rizvi-Toner A, Coe AB, Friese CR, Manojlovich M, Wallner L, Farris KB (2024) Patient symptoms, self-management, and unscheduled healthcare use during the first 6 months of targeted oral anticancer agent therapy: protocol for a mixed-methods US study. BMJ Open 14(2):e081375. https:\/\/doi.org\/10.1136\/bmjopen-2023-081375","journal-title":"BMJ Open"},{"issue":"1","key":"10421_CR25","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1097\/NCC.0b013e31824a730a","volume":"36","author":"AJ Hoffman","year":"2013","unstructured":"Hoffman AJ (2013) Enhancing self-efficacy for optimized patient outcomes through the theory of symptom self-management. Cancer Nurs 36(1):E16\u2013E26. https:\/\/doi.org\/10.1097\/NCC.0b013e31824a730a","journal-title":"Cancer Nurs"},{"issue":"5","key":"10421_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1046\/j.1365-2648.2001.01697.x","volume":"33","author":"M Dodd","year":"2001","unstructured":"Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S, Taylor D (2001) Advancing the science of symptom management. J Adv Nurs 33(5):668\u2013676. https:\/\/doi.org\/10.1046\/j.1365-2648.2001.01697.x","journal-title":"J Adv Nurs"},{"issue":"3","key":"10421_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","volume":"53","author":"D Hui","year":"2017","unstructured":"Hui D, Bruera E (2017) The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manage 53(3):630\u2013643. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.10.370","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"10421_CR28","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s10461-016-1406-x","volume":"20","author":"IB Wilson","year":"2016","unstructured":"Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH (2016) Validation of a new three-item self-report measure for medication adherence. AIDS Behav 20(11):2700\u20132708. https:\/\/doi.org\/10.1007\/s10461-016-1406-x","journal-title":"AIDS Behav"},{"issue":"3","key":"10421_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.6004\/jnccn.2018.7098","volume":"17","author":"JM Jacobs","year":"2019","unstructured":"Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, Buzaglo J, Lennes IT, Safren SA, Pirl WF, Temel JS, Greer JA (2019) Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Canc Netw 17(3):221\u2013228. https:\/\/doi.org\/10.6004\/jnccn.2018.7098","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10421_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.18553\/jmcp.2024.23134","volume":"30","author":"A Vyas","year":"2024","unstructured":"Vyas A, Parikh MA, Campbell PJ, Green A, Westrich K, Kogut S (2024) Association between adherence with oral anticancer medications and short-term health care resource utilization: a 2010-2018 claims-based analysis. J Manag Care Spec Pharm 30(4):326\u2013335. https:\/\/doi.org\/10.18553\/jmcp.2024.23134","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"10421_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1634\/theoncologist.2015-0405","volume":"21","author":"JA Greer","year":"2016","unstructured":"Greer JA, Amoyal N, Nisotel L, Fishbein JN, MacDonald J, Stagl J, Lennes I, Temel JS, Safren SA, Pirl WF (2016) A systematic review of adherence to oral antineoplastic therapies. Oncologist 21(3):354\u2013376. https:\/\/doi.org\/10.1634\/theoncologist.2015-0405","journal-title":"Oncologist"},{"issue":"3","key":"10421_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/1078155211436022","volume":"18","author":"D Bhattacharya","year":"2012","unstructured":"Bhattacharya D, Easthall C, Willoughby KA, Small M, Watson S (2012) Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Practice 18(3):333\u2013342. https:\/\/doi.org\/10.1177\/1078155211436022","journal-title":"J Oncol Pharm Practice"},{"key":"10421_CR33","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.2147\/PPA.S224496","volume":"13","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Wickersham KE, Zhang X, Barton DL, Farris KB, Krauss JC, Harris MR (2019) Side effects, self-management activities, and adherence to oral anticancer agents. Patient Prefer Adherence 13:2243\u20132252. https:\/\/doi.org\/10.2147\/PPA.S224496","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10421_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pain.2007.09.010","volume":"137","author":"LS Porter","year":"2008","unstructured":"Porter LS, Keefe FJ, Garst J, McBride CM, Baucom D (2008) Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress. Pain 137(2):306\u2013315. https:\/\/doi.org\/10.1016\/j.pain.2007.09.010","journal-title":"Pain"},{"key":"10421_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-356","volume":"14","author":"M Panagioti","year":"2014","unstructured":"Panagioti M, Richardson G, Small N, Murray E, Rogers A, Kennedy A, Newman S, Bower P (2014) Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res 14:356. https:\/\/doi.org\/10.1186\/1472-6963-14-356","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10421_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08672-3","volume":"32","author":"M Hwang","year":"2024","unstructured":"Hwang M, Cho Y, Gong Y, Jiang Y (2024) The relationship between medication beliefs, patient activation, and self-rated health in patients taking oral anticancer agents. Support Care Cancer 32(7):449. https:\/\/doi.org\/10.1007\/s00520-024-08672-3","journal-title":"Support Care Cancer"},{"issue":"2","key":"10421_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246430","volume":"16","author":"CH Chin","year":"2021","unstructured":"Chin CH, Tseng LM, Chao TC, Wang TJ, Wu SF, Liang SY (2021) Self-care as a mediator between symptom-management self-efficacy and quality of life in women with breast cancer. PLoS ONE 16(2):e0246430. https:\/\/doi.org\/10.1371\/journal.pone.0246430","journal-title":"PLoS ONE"},{"issue":"9","key":"10421_CR38","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1007\/s00520-020-05469-y","volume":"28","author":"X Skrabal Ross","year":"2020","unstructured":"Skrabal Ross X, Gunn KM, Suppiah V, Patterson P, Olver I (2020) A review of factors influencing non-adherence to oral antineoplastic drugs. Support Care Cancer 28(9):4043\u20134050. https:\/\/doi.org\/10.1007\/s00520-020-05469-y","journal-title":"Support Care Cancer"},{"issue":"9","key":"10421_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307838","volume":"19","author":"S Ucciero","year":"2024","unstructured":"Ucciero S, Lacarbonara F, Durante A, Torino F, Uchmanowicz I, Vellone E, Di Nitto M (2024) Predictors of self-care in patients with cancer treated with oral anticancer agents: a systematic review. PLoS ONE 19(9):e0307838. https:\/\/doi.org\/10.1371\/journal.pone.0307838","journal-title":"PLoS ONE"},{"issue":"17","key":"10421_CR40","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.1002\/cam4.4140","volume":"10","author":"CC Murphy","year":"2021","unstructured":"Murphy CC, Fullington HM, Gerber DE, Bowman IA, Puligandla M, Dutcher JP, DiPaola RS, Haas NB (2021) Adherence to oral therapies among patients with renal cell carcinoma: post hoc analysis of the ECOG-ACRIN E2805 trial. Cancer Med 10(17):5917\u20135924. https:\/\/doi.org\/10.1002\/cam4.4140","journal-title":"Cancer Med"},{"issue":"4","key":"10421_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/2347-5625.212864","volume":"4","author":"EE Ali","year":"2017","unstructured":"Ali EE, Cheung KL, Lee CP, Leow JL, Yap KY, Chew L (2017) Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore. Asia-Pac J Oncol Nurs 4(4):283\u2013289. https:\/\/doi.org\/10.4103\/2347-5625.212864","journal-title":"Asia-Pac J Oncol Nurs"},{"issue":"12","key":"10421_CR42","doi-asserted-by":"publisher","first-page":"e1895","DOI":"10.1200\/OP.20.01082","volume":"17","author":"SB Wheeler","year":"2021","unstructured":"Wheeler SB, Spees LP, Jackson BE, Baggett CD, Wilson LE, Greiner MA, Kaye DR, Zhang T, George D, Scales CD Jr, Pritchard JE, Dinan MA (2021) Patterns and predictors of oral anticancer agent use in diverse patients with metastatic renal cell carcinoma. JCO Oncol Pract 17(12):e1895\u2013e1904. https:\/\/doi.org\/10.1200\/OP.20.01082","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"10421_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.24793","volume":"7","author":"AK Balitsky","year":"2024","unstructured":"Balitsky AK, Rayner D, Britto J, Lionel AC, Ginsberg L, Cho W, Wilfred AM, Sardar H, Cantor N, Mian H, Levine MN, Guyatt GH (2024) Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis. JAMA Netw Open 7(8):e2424793. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.24793","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10421_CR44","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-025-03507-y","volume":"31","author":"E Basch","year":"2025","unstructured":"Basch E, Schrag D, Jansen J et al (2025) Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med 31(4):1225\u20131232. https:\/\/doi.org\/10.1038\/s41591-025-03507-y","journal-title":"Nat Med"},{"issue":"1","key":"10421_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62307-5","volume":"14","author":"CS Cleeland","year":"2024","unstructured":"Cleeland CS, Keating KN, Cuffel B, Elbi C, Siegel JM, Gerlinger C, Symonds T, Sloan JA, Dueck AC, Bottomley A, Wang XS, Williams LA, Mendoza TR (2024) Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma. Sci Rep 14(1):14839. https:\/\/doi.org\/10.1038\/s41598-024-62307-5","journal-title":"Sci Rep"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10421-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10421-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10421-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:10Z","timestamp":1773215110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10421-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10421"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10421-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by the Institutional Review Board of University of Michigan Medical School (IRBMED) and was performed in accordance with the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"KBF had funding from AstraZeneca to understand a model of collaboration between primary care and oncology pharmacists in managing patients with new oral anticancer agents. The funded study did not have any relationship with the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}